Idioma:

Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics

Murugaiyan, Jayaseelan ; Kumar, P Anand ; Rao, G Srinivasa ; Iskandar, Katia ; Hawser, Stephen ; Hays, John P ; Mohsen, Yara ; Adukkadukkam, Saranya ; Awuah, Wireko Andrew ; Jose, Ruiz Alvarez Maria ; Sylvia, Nanono ; Nansubuga, Esther Patience ; Tilocca, Bruno ; Roncada, Paola ; Roson-Calero, Natalia ; Moreno-Morales, Javier ; Amin, Rohul ; Kumar, Ballamoole Krishna ; Kumar, Abishek ; Toufik, Abdul-Rahman ; Zaw, Thaint Nadi ; Akinwotu, Oluwatosin O ; Satyaseela, Maneesh Paul ; van Dongen, Maarten B M

Antibiotics (Basel), 2022-02, Vol.11 (2), p.200 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por

Enviar para

Título:
Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics
Autor: Murugaiyan, Jayaseelan ; Kumar, P Anand ; Rao, G Srinivasa ; Iskandar, Katia ; Hawser, Stephen ; Hays, John P ; Mohsen, Yara ; Adukkadukkam, Saranya ; Awuah, Wireko Andrew ; Jose, Ruiz Alvarez Maria ; Sylvia, Nanono ; Nansubuga, Esther Patience ; Tilocca, Bruno ; Roncada, Paola ; Roson-Calero, Natalia ; Moreno-Morales, Javier ; Amin, Rohul ; Kumar, Ballamoole Krishna ; Kumar, Abishek ; Toufik, Abdul-Rahman ; Zaw, Thaint Nadi ; Akinwotu, Oluwatosin O ; Satyaseela, Maneesh Paul ; van Dongen, Maarten B M
Assuntos: Antibacterial agents ; antibiotic alternatives ; Antibiotic resistance ; Antibiotics ; Antimicrobial agents ; antimicrobial peptides ; Antimicrobial resistance ; Bacteria ; bacteriophages ; Communicable diseases ; CRISPR ; Drug delivery ; Drug delivery systems ; Drug resistance ; Drug resistance in microorganisms ; Drugs ; E coli ; enzyme inhibitors ; Enzymes ; Health aspects ; Infectious diseases ; Life Sciences ; Methicillin ; Microorganisms ; Morbidity ; Pathogens ; Penicillin ; Public health ; Review ; Staphylococcus infections ; Streptococcus infections ; Sulbactam ; Tetracycline ; Tetracyclines ; Vehicles
É parte de: Antibiotics (Basel), 2022-02, Vol.11 (2), p.200
Notas: ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
PMCID: PMC8868457
All authors are members of the Global AMR Insights Ambassador Network. For Information about the network: https://www.amr-insights.eu/about-us/ambassadors/.
Descrição: Antibiotic resistance, and, in a broader perspective, antimicrobial resistance (AMR), continues to evolve and spread beyond all boundaries. As a result, infectious diseases have become more challenging or even impossible to treat, leading to an increase in morbidity and mortality. Despite the failure of conventional, traditional antimicrobial therapy, in the past two decades, no novel class of antibiotics has been introduced. Consequently, several novel alternative strategies to combat these (multi-) drug-resistant infectious microorganisms have been identified. The purpose of this review is to gather and consider the strategies that are being applied or proposed as potential alternatives to traditional antibiotics. These strategies include combination therapy, techniques that target the enzymes or proteins responsible for antimicrobial resistance, resistant bacteria, drug delivery systems, physicochemical methods, and unconventional techniques, including the CRISPR-Cas system. These alternative strategies may have the potential to change the treatment of multi-drug-resistant pathogens in human clinical settings.
Editor: Switzerland: MDPI AG
Idioma: Inglês

Links

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics

Switzerland: MDPI AG

Buscando em bases de dados remotas. Favor aguardar.